As of 2026-08-19, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -16.65 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 20.84 USD, the upside of Cullinan Oncology Inc is -179.90%.
Based on its market price of 20.84 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 179.90%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.65 - -16.65 | -16.65 | -179.90% |
| P/E | (87.92) - (101.24) | (95.17) | -556.7% |
| DDM - Stable | (20.28) - (77.79) | (49.03) | -335.3% |
| DDM - Multi | (14.31) - (45.39) | (22.07) | -205.9% |
| Market Cap (mil) | 1,280.83 |
| Beta | 1.15 |
| Outstanding shares (mil) | 61.46 |
| Enterprise Value (mil) | 1,202.19 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.68% |
| Cost of Debt | 5.00% |
| WACC | 8.30% |